Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fiscus Ventures is a private venture capital and investment firm focused on healthcare and life sciences investing. Publicly available sources describe it as an active investor rather than an operating drug-development company, with portfolio exposure to biotechnology, medical device, diagnostics, and broader healthtech businesses. Reported portfolio companies and investments include healthcare-focused names such as Cala Health, Exo, Imvax, Vedanta Biosciences, and SomaLogic-related activity. The firm appears to be led by Ted Koutouzis and operates as a private financial sponsor supporting innovation in the healthcare sector. Because it is an investor and not a therapeutic developer, traditional biotech pipeline, modality, target, and clinical-stage fields are largely not applicable.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fiscus Venture.